The Role of Polydimethylsiloxane in the Molecular Structure of Silica Xerogels Intended for Drug Carriers
- PMID: 26839836
- PMCID: PMC4727759
- DOI: 10.3797/scipharm.1409-08
The Role of Polydimethylsiloxane in the Molecular Structure of Silica Xerogels Intended for Drug Carriers
Abstract
The aim of this study was to prepare and examine polymer/oxide xerogels with metronidazole (MT) as delivery systems for the local application of a drug to a bone. The nanoporous SiO2-CaO and PDMS-modified SiO2-CaO xerogel materials with different amounts of the polymer, polydimethylsiloxane (PDMS), were prepared by the sol-gel method. Characterization assays comprised the analysis of the composite materials by using Fourier transform infrared spectroscopy (FTIR), determining the specific surface area of solids (BET), using X-ray powder diffraction (XRD) and scanning electron microscope (SEM) techniques, and further monitoring in the ultraviolet and visible light regions (UV-Vis) of the in vitro release of the drug (metronidazole) over time. According to these results, the bioactive character and chemical stability of PDMS-modified silica xerogels have been proven. The release of MT from xerogels was strongly correlated with the composition of the matrix. In comparison with the pure oxide matrix, PDMS-modified matrices accelerated the release of the drug through its bigger pores, and additionally, on account of weaker interactions with the drug. The obtained results for the xerogel composites suggest that the metronidazole-loaded xerogels could be promising candidates for formulations in local delivery systems particularly to bone.
Keywords: Drug delivery systems; Ormosils; Sol-gel method.
Figures







Similar articles
-
The Design of Nanostructured Metronidazole-Loaded HPC/Oxide Xerogel Composites: Influence of the Formulation Parameters on In Vitro Characterisation.AAPS PharmSciTech. 2015 Oct;16(5):1160-8. doi: 10.1208/s12249-015-0310-4. Epub 2015 Feb 26. AAPS PharmSciTech. 2015. PMID: 25716331 Free PMC article.
-
The sol-gel prepared SiO2-CaO-P2O5 composites doped with Metronidazole for application in local delivery systems.Pharm Dev Technol. 2012 Nov-Dec;17(6):697-704. doi: 10.3109/10837450.2011.572894. Epub 2011 Apr 12. Pharm Dev Technol. 2012. PMID: 21480825
-
Correlation between physicochemical properties of doxorubicin-loaded silica/polydimethylsiloxane xerogel and in vitro release of drug.Acta Biomater. 2009 Jan;5(1):193-207. doi: 10.1016/j.actbio.2008.07.027. Epub 2008 Aug 6. Acta Biomater. 2009. PMID: 18755642
-
Formulation and In Vitro Characterization of Bioactive Mesoporous Silica with Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration.AAPS PharmSciTech. 2017 Nov;18(8):3163-3171. doi: 10.1208/s12249-017-0804-3. Epub 2017 May 22. AAPS PharmSciTech. 2017. PMID: 28534298
-
Silica xerogels as pharmaceutical drug carriers.Expert Opin Drug Deliv. 2009 May;6(5):485-98. doi: 10.1517/17425240902902307. Expert Opin Drug Deliv. 2009. PMID: 19413456 Review.
Cited by
-
Most Important Biomedical and Pharmaceutical Applications of Silicones.Materials (Basel). 2025 May 30;18(11):2561. doi: 10.3390/ma18112561. Materials (Basel). 2025. PMID: 40508558 Free PMC article. Review.
-
Optimization of Polydimethylsiloxane-Modified Composite Synthesis and Its Impact on Collagen Interactions: Perspectives for Biomedical Applications.Materials (Basel). 2024 Feb 24;17(5):1045. doi: 10.3390/ma17051045. Materials (Basel). 2024. PMID: 38473517 Free PMC article.
-
Modeling and Optimization of β-Galactosidase Entrapping in Polydimethylsiloxane-Modified Silica Composites.Int J Mol Sci. 2022 May 12;23(10):5395. doi: 10.3390/ijms23105395. Int J Mol Sci. 2022. PMID: 35628204 Free PMC article.
References
-
- Schmidt H. Chemistry of material preparation by the sol-gel process. J Non Cryst Solids. 1988;100:51–64. http://dx.doi.org/10.1016/0022-3093(88)90006-3 .
-
- Buckley AM, Greenblatt M. The sol-gel preparation of silica gels. J Chem Educ. 1994;71:599–602. http://dx.doi.org/10.1021/ed071p599 .
-
- Livage J, Sanchez C. Sol-gel chemistry. J Non Cryst Solids. 1992;145:11–19. http://dx.doi.org/10.1016/S0022-3093(05)80422-3 .
-
- Czarnobaj K, Czarnobaj J. Sol-gel processed porous silica carriers for the controlled release of diclofenac diethylamine. J Biomed Mater Res B Appl Biomater. 2008;87:114–120. http://dx.doi.org/10.1002/jbm.b.31076 . - PubMed
-
- Radin S, Falaize S, Lee MH, Ducheyne P. In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials. Biomaterials. 2002;23:3113–3122. http://dx.doi.org/10.1016/S0142-9612(02)00051-0 . - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources